EP1226150A4 - Tadg-15: eine in karzinomen überexprimierte extrazelluläre serinprotease - Google Patents
Tadg-15: eine in karzinomen überexprimierte extrazelluläre serinproteaseInfo
- Publication number
- EP1226150A4 EP1226150A4 EP00973739A EP00973739A EP1226150A4 EP 1226150 A4 EP1226150 A4 EP 1226150A4 EP 00973739 A EP00973739 A EP 00973739A EP 00973739 A EP00973739 A EP 00973739A EP 1226150 A4 EP1226150 A4 EP 1226150A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tadg
- carcinomas
- serine protease
- extracellular serine
- protease overexpressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000009030 Carcinoma Diseases 0.000 title 1
- 101710108755 Extracellular serine protease Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07118615A EP1887082A3 (de) | 1999-10-20 | 2000-10-20 | TADG-15: Eine extrazelluläre Serinprotease die in Karzinomen überexprimiert wird |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US421213 | 1999-10-20 | ||
US09/421,213 US7022821B1 (en) | 1998-02-20 | 1999-10-20 | Antibody kit for the detection of TADG-15 protein |
PCT/US2000/029095 WO2001029056A1 (en) | 1999-10-20 | 2000-10-20 | Tadg-15: an extracellular serine protease overexpressed in carcinomas |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07118615A Division EP1887082A3 (de) | 1999-10-20 | 2000-10-20 | TADG-15: Eine extrazelluläre Serinprotease die in Karzinomen überexprimiert wird |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1226150A1 EP1226150A1 (de) | 2002-07-31 |
EP1226150A4 true EP1226150A4 (de) | 2005-05-25 |
Family
ID=23669632
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00973739A Withdrawn EP1226150A4 (de) | 1999-10-20 | 2000-10-20 | Tadg-15: eine in karzinomen überexprimierte extrazelluläre serinprotease |
EP07118615A Withdrawn EP1887082A3 (de) | 1999-10-20 | 2000-10-20 | TADG-15: Eine extrazelluläre Serinprotease die in Karzinomen überexprimiert wird |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07118615A Withdrawn EP1887082A3 (de) | 1999-10-20 | 2000-10-20 | TADG-15: Eine extrazelluläre Serinprotease die in Karzinomen überexprimiert wird |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP1226150A4 (de) |
JP (1) | JP2003512036A (de) |
AU (1) | AU774106B2 (de) |
CA (1) | CA2388450C (de) |
MX (1) | MXPA02004046A (de) |
WO (1) | WO2001029056A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7022100B1 (en) | 1999-09-03 | 2006-04-04 | A-Med Systems, Inc. | Guidable intravascular blood pump and related methods |
US7795211B2 (en) * | 2000-02-22 | 2010-09-14 | Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian cancer |
US7157596B2 (en) | 2000-09-08 | 2007-01-02 | Dendreon Corporation | Inhibitors of serine protease activity of matriptase or MTSP1 |
US7019019B2 (en) | 2002-12-23 | 2006-03-28 | Dendreon Corporation | Matriptase inhibitors and methods of use |
EP1838737B1 (de) | 2004-12-20 | 2011-04-06 | Amgen Fremont Inc. | Für humane matriptase spezifische bindungsproteine |
GB0611116D0 (en) * | 2006-06-06 | 2006-07-19 | Oxford Genome Sciences Uk Ltd | Proteins |
AU2008284271B2 (en) * | 2007-08-07 | 2014-03-13 | E. R. Squibb & Sons, L.L.C. | Matriptase protein and uses thereof |
EP2427479B1 (de) | 2009-05-07 | 2018-11-21 | The Regents of The University of California | Antikörper und verfahren zu ihrer verwendung |
US8455200B2 (en) | 2009-10-15 | 2013-06-04 | Traxxsson, Llc | Measurement of PKA for cancer detection |
US20120231479A1 (en) | 2010-09-09 | 2012-09-13 | Robert Puskas | Combination methods of diagnosing cancer in a patient |
US9255155B2 (en) | 2013-01-31 | 2016-02-09 | The Regents Of The University Of California | Antibodies specific for urokinase-type plasminogen activator and methods of treating cancer |
US9932411B2 (en) | 2013-11-25 | 2018-04-03 | Oxford Biotherapeutics Ltd | Antibodies |
US9272027B1 (en) | 2014-09-08 | 2016-03-01 | The United States Of America As Represented By The Secretary Of The Air Force | Francisella tularensis live vaccine strains and methods of use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041656A1 (en) * | 1997-03-19 | 1998-09-24 | The Board Of Trustees Of The University Of Arkansas | Compositions and method for the early diagnosis of ovarian cancer |
WO1999036550A2 (en) * | 1998-01-16 | 1999-07-22 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
WO1999042120A1 (en) * | 1998-02-20 | 1999-08-26 | The Board Of Trustees Of The University Of Arkansas | Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09149790A (ja) * | 1995-09-29 | 1997-06-10 | Suntory Ltd | 新規セリンプロテアーゼ |
EP1151113A2 (de) * | 1999-01-11 | 2001-11-07 | Incyte Pharmaceuticals, Inc. | Menschliche peptidasen |
JP4778617B2 (ja) * | 1999-03-12 | 2011-09-21 | ジョージタウン ユニバーシティ | マトリプターゼ、セリンプロテアーゼおよびその応用 |
-
2000
- 2000-10-20 CA CA2388450A patent/CA2388450C/en not_active Expired - Fee Related
- 2000-10-20 JP JP2001531854A patent/JP2003512036A/ja active Pending
- 2000-10-20 AU AU12215/01A patent/AU774106B2/en not_active Ceased
- 2000-10-20 WO PCT/US2000/029095 patent/WO2001029056A1/en active IP Right Grant
- 2000-10-20 EP EP00973739A patent/EP1226150A4/de not_active Withdrawn
- 2000-10-20 MX MXPA02004046A patent/MXPA02004046A/es active IP Right Grant
- 2000-10-20 EP EP07118615A patent/EP1887082A3/de not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998041656A1 (en) * | 1997-03-19 | 1998-09-24 | The Board Of Trustees Of The University Of Arkansas | Compositions and method for the early diagnosis of ovarian cancer |
WO1999036550A2 (en) * | 1998-01-16 | 1999-07-22 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
WO1999042120A1 (en) * | 1998-02-20 | 1999-08-26 | The Board Of Trustees Of The University Of Arkansas | Tadg-15: an extracellular serine protease overexpressed in breast and ovarian carcinomas |
Non-Patent Citations (1)
Title |
---|
See also references of WO0129056A1 * |
Also Published As
Publication number | Publication date |
---|---|
MXPA02004046A (es) | 2002-10-11 |
EP1887082A3 (de) | 2008-06-11 |
CA2388450C (en) | 2013-02-12 |
EP1887082A2 (de) | 2008-02-13 |
CA2388450A1 (en) | 2001-04-26 |
WO2001029056A1 (en) | 2001-04-26 |
AU774106B2 (en) | 2004-06-17 |
JP2003512036A (ja) | 2003-04-02 |
EP1226150A1 (de) | 2002-07-31 |
AU1221501A (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA992447B (en) | Quinoxalinones as serine protease inhibitors. | |
EP1157035A4 (de) | In eierstock-karzinomen überexprimierte transmembran-serinprotease und deren anwendungen | |
AU139162S (en) | Footwear | |
ZA992448B (en) | Quinoxalinones as serine protease inhibitors. | |
HK1054571A1 (zh) | 新的蛋白酶 | |
AU140155S (en) | Footwear | |
AU2001269448A1 (en) | Water supply | |
SG106633A1 (en) | Polishing system | |
EP1226150A4 (de) | Tadg-15: eine in karzinomen überexprimierte extrazelluläre serinprotease | |
EP1179052A4 (de) | Serinproteasen | |
GB9800817D0 (en) | Serine protease inhibitors | |
EP1244780A4 (de) | Für humane serinprotease t kodierendes gen | |
GB0127466D0 (en) | Improvements in footwear | |
AU5290499A (en) | Human htra serine protease | |
SG96553A1 (en) | Abrasive | |
AU1368002A (en) | Sander | |
AU1624501A (en) | Human serine protease | |
GB0107142D0 (en) | Comminution machine | |
EP1132473A4 (de) | Serinprotease bssp6 | |
EP1206233A4 (de) | Serin-proteasen | |
EP1214401A4 (de) | DNS, WELCHE FüR HUMANE SERINPROTEASE C-E KODIERT | |
EP1132477A4 (de) | Serinprotease bssp4 | |
AU2542100A (en) | Protease | |
AU2001238721A1 (en) | Human serine protease | |
GB2361621B (en) | Footwear |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020419 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050406 |
|
17Q | First examination report despatched |
Effective date: 20050928 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20071030 |